Dr. Christopher Frederick Blodi, MD

Dr. Blodi practices at Broadlawns Medical Center in Des Moines, Iowa, part of Polk County Iowa.

Dr. Blodi's NPI, 1689642290, was assigned on March 9, 2006. Dr. Blodi graduated from WashU Medicine in 1979. Dr. Blodi's Nebraska license number on file is 31257.

Dr. Blodi's primary practice is Broadlawns Medical Center, at 1801 Hickman Road, Des Moines, IA 50314 in Polk County. The practice phone is (515) 282-2200.

Dr. Blodi's primary practice is Broadlawns Medical Center in Des Moines, Iowa, part of Polk County Iowa. The medical group on file is Broadlawns Medical Center. Dr. Blodi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blodi practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Blodi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Blodi is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Blodi's licenses on file in 3 states: Nebraska, Iowa and Florida.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, glaucoma, inflammation of iris, laser destruction of retinal or choroid lesions and retinal occlusion among the conditions Dr. Blodi treats.

CMS data shows 183 Medicare services from Dr. Blodi across 4 procedure codes in 2024, for 78 Medicare patients. Medicare paid $7,234 for them.

CMS counts 78 Medicare patients who saw Dr. Blodi in 2026. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 63% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blodi's median patient age at 64, with 55% women.

In 2026, Dr. Blodi wrote 131 Medicare Part D claims for 27 patients. 51% of them were for generic drugs. CMS names the drug for 88 of them, across 5 drugs with 11 or more claims each, at $3,460 in total drug cost. In 2023, CMS named 77 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Blodi for performance year 2026, reported as part of a group. Dr. Blodi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 29 papers to Dr. Blodi, published from 2013 to 2022. The most frequent topics are Visual Acuity, Fundus Oculi and Retinal Detachment. Dr. Blodi has published most often in Ophthalmology. Dr. Blodi's most frequent co-authors are Harry W. Flynn, MD, Brian B. Berger, MD and John G. Clarkson, MD.

CMS Open Payments shows 22 general payments to Dr. Blodi from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $727.

Dmand AI lists 3 awards for Dr. Blodi, most recently Distinguished Service Award in 2007.

Dr. Blodi graduated from WashU Medicine in 1979. Dr. Blodi is a member of AAO, ASRS, Cogan Ophthalmic History Society, Macula Society and Retina Society.

Dr. Blodi is in network with 13 carriers, including United Healthcare, HCSC and Humana. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.